{
  "id": 151247,
  "name": "PLASMA PROTEIN THERAPEUTICS ASSOCIATION",
  "slug": "plasma-protein-therapeutics-association",
  "state": "MD",
  "description": null,
  "totalSpending": 1450000,
  "filings": 29,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 150000
    },
    {
      "year": 2019,
      "income": 200000
    },
    {
      "year": 2020,
      "income": 200000
    },
    {
      "year": 2021,
      "income": 200000
    },
    {
      "year": 2022,
      "income": 100000
    },
    {
      "year": 2023,
      "income": 200000
    },
    {
      "year": 2024,
      "income": 200000
    },
    {
      "year": 2025,
      "income": 200000
    }
  ],
  "firms": [
    "WILLIAMS AND JENSEN, PLLC"
  ],
  "lobbyists": [
    "GEORGE OLSEN",
    "CHRISTOPHER HATCHER",
    "NICHOLAS KARELLAS",
    "ANDREW JONES",
    "JENNIFER WANANDI",
    "MELINDA MAXFIELD",
    "NICOLE BERTSCH",
    "LAURA SIMMONS",
    "CHRISTOPHER WILCOX",
    "KARINA LYNCH",
    "MATTHEW HOEKSTRA",
    "GEORGE BAKER",
    "MARTI THOMAS",
    "FRANK VLOSSAK",
    "CHERYL JAEGER",
    "DAVID STARR",
    "GRANT BARBOSA",
    "JEANNE HAGGERTY",
    "ALEC ARAMANDA",
    "KURT SCHRADER",
    "ROBERT BUTORA"
  ],
  "issues": [
    "TAX",
    "HCR",
    "MMM",
    "BUD",
    null,
    "TRD"
  ],
  "sampleDescriptions": [
    "Comprehensive Tax reform; Orphan Drug Tax and Credit; Research and Development Tax Credit.",
    "Drug safety and drug counterfeiting; drug importation; H.R. 4724, Medicare IVIG Access Enhancement Act.",
    "Payment policies for Medicare Part B prescription drugs; Medicare drug coverage and payment policy; for plasma products.",
    "Payment policies for Medicare Part B prescription drugs; Medicare drug coverage and payment policies for plasma protein products.",
    "Drug safety and drug counterfeiting; drug importation; H.R. 4724, Medicare IVIG Access Enhancement Act.  Policies affecting pre-existing condition protections.",
    "Tax legislation affecting the Orphan Drug Tax Credit and the Research and Development Tax Credit.",
    "Drug safety and drug counterfeiting; Medicare IVIG Access Enhancement Act; Policies affecting pre-existing condition protections;  Drug importation including S. 61 and H.R. 478, Safe and Affordable Drugs from Canada Act of 2019; S. 97 and H.R. 447, Affordable and Safe Prescription Drug Importation Act.",
    "Drug safety and drug counterfeiting; H.R. 2905, Medicare IVIG Access Enhancement Act; Policies affecting pre-existing condition protections;  Drug importation including S. 61 and H.R. 478, Safe and Affordable Drugs from Canada Act of 2019; S. 97 and H.R. 447, Affordable and Safe Prescription Drug Importation Act;  S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019 and H.R. 3, Lower Drug Costs Now Act of 2019; Supply of intravenous immunoglobulin.",
    "Payment policies for Medicare Part B prescription drugs; Medicare drug coverage and payment policies for plasma protein products.  S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019 and H.R. 3, Lower Drug Costs Now Act of 2019.",
    "Payment policies for Medicare Part B prescription drugs; Medicare drug coverage and payment policies for plasma protein products.  S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019 and H.R. 3, Lower Drug Costs Now Act of 2019.  H.R. 1865, Further Consolidated Appropriations Act 2020.",
    "Drug safety and drug counterfeiting; H.R. 2905, Medicare IVIG Access Enhancement Act; Policies affecting pre-existing condition protections;  Drug importation including S. 61 and H.R. 478, Safe and Affordable Drugs from Canada Act of 2019; S. 97 and H.R. 447, Affordable and Safe Prescription Drug Importation Act;  S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019 and H.R. 3, Lower Drug Costs Now Act of 2019; Supply of intravenous immunoglobulin.  S.3548/H.R. 748, Coronavirus Aid, Relief, and Economic Security Act; H.R. 6201, Families First Coronavirus Response Act; and H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020.",
    "Drug safety and drug counterfeiting; H.R. 2905, Medicare IVIG Access Enhancement Act; Policies affecting pre-existing condition protections;  Drug importation including S. 61 and H.R. 478, Safe and Affordable Drugs from Canada Act of 2019; S. 97 and H.R. 447, Affordable and Safe Prescription Drug Importation Act;  S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019 and H.R. 3; Lower Drug Costs Now Act of 2019;  Policies impacting the U.S. response to the COVID-19 pandemic including H.R. 604, the Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law No. 116-123; H.R. 6201, Families First Coronavirus Response Act, Public Law No. 116-127; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act\"), Public Law No. 116-136; and H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act\").",
    "Payment policies for Medicare Part B prescription drugs; Medicare drug coverage and payment policies for plasma protein products.   Medicare coverage and payment for home infusion of drugs generally and during the COVID-19 public health emergency. Policies impacting the U.S. response to the COVID-19 pandemic including H.R. 604, the Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law No. 116-123; H.R. 6201, Families First Coronavirus Response Act, Public Law No. 116-127; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), Public Law No. 116-136; and H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act).   S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019 and H.R. 3, Lower Drug Costs Now Act of 2019.",
    "H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act.",
    "Drug safety and drug counterfeiting; H.R. 2905, Medicare IVIG Access Enhancement Act; Policies affecting pre-existing condition protections;  Drug importation including S. 61 and H.R. 478, Safe and Affordable Drugs from Canada Act of 2019; S. 97 and H.R. 447, Affordable and Safe Prescription Drug Importation Act;  S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019 and H.R. 3; Lower Drug Costs Now Act of 2019;  Policies impacting the U.S. response to the COVID-19 pandemic including H.R. 604, the Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law No. 116-123; H.R. 6201, Families First Coronavirus Response Act, Public Law No. 116-127; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act\"), Public Law No. 116-136; and H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act\").   Education regarding Executive Orders impacting drug pricing including Medicare rebate reform, the 340B drug discount program, Buy America requirements, drug importation, and imposition of most favored nation pricing on drugs under Medicare Parts B and D.  Legislation to increase awareness of need for plasma donations including H.R. 7783/S. 4179, the Plasma Donation Awareness Act of 2020.",
    "Payment policies for Medicare Part B prescription drugs; Medicare drug coverage and payment policies for plasma protein products.   Medicare coverage and payment for home infusion of drugs generally and during the COVID-19 public health emergency. Policies impacting the U.S. response to the COVID-19 pandemic including H.R. 604, the Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law No. 116-123; H.R. 6201, Families First Coronavirus Response Act, Public Law No. 116-127; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), Public Law No. 116-136; and H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act).   S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019 and H.R. 3, Lower Drug Costs Now Act of 2019.  Education regarding Executive Orders impacting drug pricing including Medicare rebate reform, the 340B drug discount program, Buy America requirements, drug importation, and imposition of most favored nation pricing on drugs under Medicare Parts B and D.  H.R. 7839, the Continuing Access to In-Home IVIG Act.",
    "H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act.  H.R. 133, Consolidated Appropriations Act, 2021, Pub. L. No. 116-260.",
    "Payment policies for Medicare Part B prescription drugs; Medicare drug coverage and payment policies for plasma protein products.   Medicare coverage and payment for home infusion of drugs generally and during the COVID-19 public health emergency. Policies impacting the U.S. response to the COVID-19 pandemic including H.R. 604, the Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law No. 116-123; H.R. 6201, Families First Coronavirus Response Act, Public Law No. 116-127; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act), Public Law No. 116-136; and H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act).   S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019 and H.R. 3, Lower Drug Costs Now Act of 2019.  Education regarding Executive Orders impacting drug pricing including Medicare rebate reform, the 340B drug discount program, Buy America requirements, drug importation, and imposition of most favored nation pricing on drugs under Medicare Parts B and D.  H.R. 7839, the Continuing Access to In-Home IVIG Act.  H.R. 133, Consolidated Appropriations Act, 2021, Pub. L. No. 116-260.",
    "Drug safety and drug counterfeiting; H.R. 2905, Medicare IVIG Access Enhancement Act; Policies affecting pre-existing condition protections;  Drug importation including S. 61 and H.R. 478, Safe and Affordable Drugs from Canada Act of 2019; S. 97 and H.R. 447, Affordable and Safe Prescription Drug Importation Act;  S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019 and H.R. 3; Lower Drug Costs Now Act of 2019;  Policies impacting the U.S. response to the COVID-19 pandemic including H.R. 604, the Coronavirus Preparedness and Response Supplemental Appropriations Act, Public Law No. 116-123; H.R. 6201, Families First Coronavirus Response Act, Public Law No. 116-127; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act\"), Public Law No. 116-136; and H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act\").   Education regarding Executive Orders impacting drug pricing including Medicare rebate reform, the 340B drug discount program, Buy America requirements, drug importation, and imposition of most favored nation pricing on drugs under Medicare Parts B and D.  Legislation to increase awareness of need for plasma donations including H.R. 7783/S. 4179, the Plasma Donation Awareness Act of 2020.  H.R. 133, Consolidated Appropriations Act, 2021, Pub. L. No. 116-260.",
    "Policies to ensure an adequate supply of blood plasma; Drug safety and drug counterfeiting; Policies affecting pre-existing condition protections;  Drug importation; Policies impacting the U.S. response to the COVID-19 pandemic; Legislation impacting drug pricing including Medicare rebate reform, the 340B drug discount program, Buy America requirements, and imposition of most favored nation pricing on drugs under Medicare Parts B and D.  Legislation to increase awareness of need for plasma donations. Budget reconciliation and the American Rescue Plan Act of 2021 (H.R. 1319, now Public Law No. 117-2)."
  ],
  "years": [
    2018,
    2019,
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": 33,
  "trajectory": "growing",
  "yearsActive": 8,
  "avgAnnualSpending": 181250,
  "peakYear": 2019,
  "lobbyistCount": 21,
  "firmCount": 1,
  "issueCount": 5
}